- Recent Funding
- Investors
- MorphoSys
MorphoSys portfolio
MorphoSys has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is HI-Bio's $120M Series A round in November 2022, alongside ARCH Venture Partners, Monograph Capital and Jeito Capital. That company is in Health and bio.
What MorphoSys invests in
- Health and bio · 1 · 100%
How MorphoSys invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $120M |
MorphoSys portfolio companies
| Company | Round with MorphoSys | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $120M | $215M | Jan 4, 2024 Series B+ |
Most frequent co-investors
AARCH Venture Partners1 shared round · last Nov 1, 2022
MMonograph Capital1 shared round · last Nov 1, 2022
JJeito Capital1 shared round · last Nov 1, 2022
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name MorphoSys. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists MorphoSys, which is a subset of its real portfolio. API: /api/v1/investors/morphosys (get a free API key). More: the most active VC firms and new venture capital funds.